1,3-diisopropylcarbodiimide | CAS:693-13-0

We serve 1,3-diisopropylcarbodiimide CAS:693-13-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1,3-diisopropylcarbodiimide

Chemical Name:1,3-diisopropylcarbodiimide
CAS.NO:693-13-0
Synonyms:Diisopropylcarbodiimide;DIPCDI;DIC
Molecular Formula:C7H14N2
Molecular Weight:126.19900
 
Physical and Chemical Properties:
Density:0.815;
Boiling point:145-148oC;
Flash point:33oC;
 
HS Code: 2933990099
UN No.: UN2811
Hazard class: 6.1 categories 
Packing level: Class I
 
Specification:
Appearance:Colorless to pale yellow liquid
Purity(GC):≥99.0%
 
Packing:20 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent



Contact us for information like 1,3-diisopropylcarbodiimide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DIC physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,DIC Use and application,1,3-diisopropylcarbodiimide technical grade,usp/ep/jp grade.


Related News: ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.2-Ethoxythiazole manufacturer In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .6-Bromo-2-chloro-3-iodopyridine supplier The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.2-Bromo-5-fluoro-3-methylpyridine vendor If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said.It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.